熱門資訊> 正文
Trxade Health以价值1.03亿美元的全股票交易收购Sciencia
2024-07-26 22:47
- TRxADE HEALTH (NASDAQ:MEDS) and Scienture has announced the closing of TRxADE’s business combination with Scienture in an all-stock transaction.
- TRxADE acquired all of Scienture’s assets in exchange for shares of TRxADE stock, in a combination of common stock and non-voting convertible preferred stock.
- TRxADE will change its name to “Scienture Holdings” after the future conversion of the non-voting convertible preferred stock, and the combined company is intended to continue as a Nasdaq-listed Co.
- The Business Combination results in a combined Co. that will be focused on bringing to market innovative branded, specialty pharmaceutical products that significantly enhance the standard of care, while adding value to patients, caregivers and the healthcare system.
More on Trxade Group
- Financial information for Trxade Group
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
